Results 41 to 50 of about 999 (177)
Concomitant septal myectomy and mitral valve repair in a child with Noonan syndrome
Clinical Case Reports, 2021 We successfully performed concomitant septal myectomy and mitral valve repair in a child with Noonan syndrome.
Toshio Doi +5 more
doaj +1 more source
Reviews in Cardiovascular Medicine, 2022 Background: Hypertrophic obstructive cardiomyopathy (HOCM) with severe mitral regurgitation (MR) remains controversial for the choice of the concomitant mitral valve (MV) management versus septal myectomy alone.
Fangyu Liu +6 more
doaj +1 more source
Computer simulation of surgical interventions for the treatment of refractory pulmonary hypertension [PDF]
arXiv, 2021 This paper describes computer models of three interventions used for treating refractory pulmonary hypertension (RPH). These procedures create either an atrial septal defect, a ventricular septal defect, or, in the case of a Potts shunt, a patent ductus arteriosus.
arxiv
The Thoracic & Cardiovascular Surgeon Reports, 2015 Background Transarterial valve intervention (TAVI) is valuable in high-risk patients, however, in case of left ventricular outflow tract (LVOT) obstruction, conventional surgery, including partial myectomy, is indicated.
Torsten Christ +4 more
doaj +1 more source
Myectomy or Alcohol Septal Ablation
Journal of the American College of Cardiology, 2007 Since the development of alcohol septal ablation by Sigwart ([1][1]) and its increasing adoption, the treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM) with myectomy versus alcohol septal ablation has generated a passion of debate and disagreement not often seen.
Duke E. Cameron +3 more
openaire +2 more sources
Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
Frontiers in Cardiovascular Medicine, 2021 Hypertrophic cardiomyopathy is an inherited cardiovascular disease, and 70% of patients have left ventricular outflow tract obstruction. Ventricular septal myectomy has been the gold standard treatment for most patients with refractory symptoms.
Miaomiao He +5 more
doaj +1 more source
SEPTAL MYECTOMY DOES NOT IMPROVE SEPTAL MYOCARDIAL EFFICIENCY IN HYPERTROPHIC CARDIOMYOPATHY [PDF]
Journal of the American College of Cardiology, 2015 Next to left ventricular hypertrophy, hypertrophic obstructive cardiomyopathy (HOCM) is characterized by reduced myocardial external efficiency. Septal myectomy improves symptoms and prognosis. This study was conducted to study the effects of septal myectomy on regional (septal and lateral)
A.F.L. Schinkel +9 more
openaire +1 more source
MODIFIED TECHNIQUE OF MANAGEMENT FOR DISCRETE AND DIFFUSE SUBAORTIC STENOSIS
Неотложная медицинская помощь, 2017 We report a new original method of management for subaortic stenosis. When performing myectomy from the transaortic access of Morrow, the significant problem is poor visualization of the interventricular septum.
M. A. Martakov +3 more
doaj +1 more source
ESC Heart Failure, EarlyView.Abstract Aims No curative treatment is available for RASopathy‐associated childhood‐onset hypertrophic cardiomyopathy (RAS‐CM). Preclinical data and individual reports suggest a beneficial effect of small molecules targeting the RAS–mitogen‐activated protein (MAP) kinase (MAPK) pathway in severely affected RAS‐CM patients.
Jules Hamers +11 more
wiley +1 more source
A New Causal Rule Learning Approach to Interpretable Estimation of Heterogeneous Treatment Effect [PDF]
arXiv, 2023 Interpretability plays a critical role in the application of statistical learning for estimating heterogeneous treatment effects (HTE) for complex diseases. In this study, we leverage a rule-based workflow, namely causal rule learning (CRL) to estimate and enhance our understanding of HTE for atrial septal defect, addressing an overlooked question in ...
arxiv